Avenue Therapeutics, Inc. (ATXI)
OTCMKTS · Delayed Price · Currency is USD
0.4300
+0.0100 (2.38%)
At close: Oct 14, 2026
Avenue Therapeutics Market Cap
Avenue Therapeutics has a market cap or net worth of $1.42 million as of October 16, 2026. It is the 48,775th most valuable company in the world and the 6,608th biggest in the United States. Its market cap has decreased by 37.33% in one year.
Market Cap
1.42M
Enterprise Value
-525.17K
Revenue
n/a
Global Rank
Country Rank
#6,608 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since June 27, 2017, Avenue Therapeutics's market cap has decreased from 27.57M to 1.42M, a decrease of -94.86%. That is a compound annual growth rate of -27.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 1.42M | -34.57% |
| Dec 31, 2025 | 2.17M | -47.28% |
| Dec 31, 2024 | 4.11M | 92.60% |
| Dec 29, 2023 | 2.13M | -61.53% |
| Dec 30, 2022 | 5.54M | -70.79% |
| Dec 31, 2021 | 18.98M | -80.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AccuStem Sciences | 2.37M |
| BioAtla | 2.27M |
| International Stem Cell | 2.25M |
| CASI Pharmaceuticals | 2.06M |
| NKGen Biotech | 1.44M |
| Protagenic Therapeutics | 1.36M |
| inTerra Resources | 1.30M |
| AXIM Biotechnologies | 1.23M |